Pentagon opens biotech R&D pipeline to private companies with minimal public oversight
H.R. 5186 — To authorize the Secretary of Defense to carry out a program to support the defense biotechnology supply chain, and for other purposes. · Filed by Ro Khanna (D-CA) · 2 cosponsors · Introduced Sep 8, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill authorizes the Department of Defense to establish a program supporting the defense biotechnology supply chain by conducting research, developing bio-based materials and fuels, upgrading laboratory infrastructure, and partnering with private companies and universities. The program aims to reduce reliance on foreign suppliers and create a skilled biomanufacturing workforce, with annual reporting to Congress and a 10-year sunset clause (extendable by presidential determination).
Why we flagged it
The bill establishes a federal program to develop biotechnology capabilities for military supply-chain resilience through partnerships with private companies, academic institutions, and federal agencies. It is fundamentally an industrial policy mechanism using defense procurement authority to subsidize and coordinate private biotech development.
What the text implies
- The bill grants SecDef broad authority to enter into 'contracts, cooperative agreements, grants, or other transactions' with private entities without specifying cost-sharing ratios, intellectual property ownership, or clawback provisions—potentially transferring public R&D investment to private profit.
- The 'other purposes' language in the title is vague; the bill's scope is limited to biotechnology supply chain, but the phrase may signal additional authorities not detailed in the provided text.
The full analysis lists 5 implications of this text.
Who stands to gain
biotechnology companies (especially those in biomanufacturing and advanced materials); defense contractors with biotech divisions; academic research institutions